Europe Biopharmaceuticals Market

Europe Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service, Raw Material (Excipients, API, Others), Classification (Innovative, Biogenerics and Biosimilars), Therapeutic Area, and Country: Trend Forecast and Growth Opportunity

Europe Biopharmaceuticals Market

Europe Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service, Raw Material (Excipients, API, Others), Classification (Innovative, Biogenerics and Biosimilars), Therapeutic Area, and Country: Trend Forecast and Growth Opportunity


The Europe Biopharmaceuticals study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

Europe biopharmaceuticals market was valued at $116.5 billion in 2023 and will grow by 8.6% annually over 2023-2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, growing clinical trials and approvals for novel biomedicines, escalating healthcare spending, and favorable reimbursement policies.

Highlighted with 43 tables and 86 figures, this 160-page report “Europe Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service, Raw Material (Excipients, API, Others), Classification (Innovative, Biogenerics and Biosimilars), Therapeutic Area, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Europe biopharmaceuticals market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2021-2023 and provides a forecast from 2024 till 2033 with 2023 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure

• Growth Drivers

• Restraints and Challenges

• Emerging Product Trends & Market Opportunities

• Porter’s Fiver Forces

The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify the Europe biopharmaceuticals market in every aspect of the classification from perspectives of Product Type, Testing Service, Raw Material, Classification, Therapeutic Area and Country.

Based on Product Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.

• Monoclonal Antibodies

o Anti-cancer Monoclonal Antibodies

o Anti-inflammatory Monoclonal Antibodies

o Other Monoclonal Antibodies

• Recombinant Growth Factors

o Erythropoietin

o Granulocyte Colony Stimulating Factor

• Purified Proteins

o Leukemia Inhibitory Factor (LIF)

o P53 Protein

o P38 Protein

o Other Purified Proteins

• Recombinant Proteins

o Serum Albumin

o Amyloid Protein

o Defensin

o Transferrin

• Recombinant Hormones

o Recombinant Human Growth Hormones

o Recombinant Insulin

o Other Recombinant Hormones

• Vaccines

o Recombinant Vaccines

 Cancer Vaccines

 Malaria Vaccines

 Ebola Vaccines

 Hepatitis Vaccines

 Tetanus Vaccines

 Diphtheria Vaccines

 Cholera Vaccines

 Other Recombinant Vaccines

o Conventional Vaccines

 Polio Vaccines

 Pox Vaccines

 Other Conventional Vaccines

• Recombinant Enzymes

o Enterokinase

o Cyclase

o Caspase

o Cathepsin

• Cell and Gene Therapies

o Allogenic Products

o Autologous Products

o Acellular Products

• Synthetic Immunomodulators

• Other Product Types

o Blood Factors

o Other Products

Based on Testing Service, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.

• Laboratory Testing

• Custom Testing/Customer Proprietary Testing

• Compendial and Multi Compendial Laboratory Testing

By Raw Material, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.

• Formulation Excipients

• Active Pharmaceutical Ingredients (API)

• Other Materials

By Classification, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.

• Innovative Biopharmaceuticals

• Biogenerics and Biosimilars

By Therapeutic Area, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2033 included in each section.

• Oncology

• Inflammatory and Infectious Diseases

• Autoimmune Disorders

• Metabolic Disorders

• Hormonal Disorders

• Cardiovascular Diseases

• Neurological Diseases

• Other Therapeutic Areas

Geographically, the following national/local markets are fully investigated:

• Germany

• UK

• France

• Spain

• Italy

• Netherlands

• Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2023-2033. The breakdown of national markets by Product Type and Therapeutic Area over the forecast years are also included.

The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

Abbott Laboratories

Amgen Inc.

Astrazeneca PLC

Bayer AG

Biogen Inc.

Bristol-myers Squibb Company (BMS)

Eli Lilly and Company

F. Hoffmann-La Roche Ltd.

Glaxosmithkline PLC

Johnson & Johnson

Merck & Co. Inc.

Novartis Ag

Novo Nordisk As

Pfizer Inc.

Sanofi Sa

Sharp Packaging Services

Sun Pharmaceutical Industries Ltd.

Takeda Pharmaceutical Company Limited

Thermo Fisher Scientific Inc.

Vertex Pharmaceuticals

WuXi AppTec

(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

1 Introduction 9

1.1 Industry Definition and Research Scope 9

1.1.1 Industry Definition 9

1.1.2 Research Scope 10

1.2 Research Methodology 13

1.2.1 Overview of Market Research Methodology 13

1.2.2 Market Assumption 14

1.2.3 Secondary Data 14

1.2.4 Primary Data 14

1.2.5 Data Filtration and Model Design 15

1.2.6 Market Size/Share Estimation 16

1.2.7 Research Limitations 17

1.3 Executive Summary 18

2 Market Overview and Dynamics 21

2.1 Market Size and Forecast 21

2.1.1 Impact of COVID-19 on World Economy 22

2.1.2 Impact of COVID-19 on the Market 26

2.1.3 Impact of Russia-Ukraine Conflict 28

2.1.4 Impact of Israel-Palestine War 30

2.2 Major Growth Drivers 31

2.3 Market Restraints and Challenges 40

2.4 Emerging Opportunities and Market Trends 43

2.5 Porter’s Fiver Forces Analysis 47

3 Segmentation of Europe Market by Product Type 51

3.1 Market Overview by Product Type 51

3.2 Monoclonal Antibodies 53

3.2.1 Anti-cancer Monoclonal Antibodies 54

3.2.2 Anti-inflammatory Monoclonal Antibodies 55

3.2.3 Other Monoclonal Antibodies 56

3.3 Recombinant Growth Factors 57

3.3.1 Erythropoietin 58

3.3.2 Granulocyte Colony Stimulating Factor 59

3.4 Purified Proteins 60

3.4.1 Leukemia Inhibitory Factor (LIF) 61

3.4.2 P53 Protein 62

3.4.3 P38 Protein 63

3.4.4 Other Purified Proteins 64

3.5 Recombinant Proteins 65

3.5.1 Serum Albumin 66

3.5.2 Amyloid Protein 67

3.5.3 Defensin 68

3.5.4 Transferrin 69

3.6 Recombinant Hormones 70

3.6.1 Recombinant Human Growth Hormones 71

3.6.2 Recombinant Insulin 73

3.6.3 Other Recombinant Hormones 74

3.7 Vaccines 75

3.7.1 Recombinant Vaccines 76

3.7.2 Conventional Vaccines 78

3.8 Recombinant Enzymes 79

3.8.1 Enterokinase 80

3.8.2 Cyclase 81

3.8.3 Caspase 82

3.8.4 Cathepsin 83

3.9 Cell and Gene Therapies 84

3.9.1 Allogenic Products 85

3.9.2 Autologous Products 86

3.9.3 Acellular Products 87

3.10 Synthetic Immunomodulators 88

3.11 Other Product Types 89

3.11.1 Blood Factors 90

3.11.2 Other Products 91

4 Segmentation of Europe Market by Testing Service 92

4.1 Market Overview by Testing Service 92

4.2 Laboratory Testing 94

4.3 Custom Testing/Customer Proprietary Testing 95

4.4 Compendial and Multi Compendial Laboratory Testing 96

5 Segmentation of Europe Market by Raw Material 97

5.1 Market Overview by Raw Material 97

5.2 Formulation Excipients 99

5.3 Active Pharmaceutical Ingredients (API) 100

5.4 Other Materials 101

6 Segmentation of Europe Market by Classification 102

6.1 Market Overview by Classification 102

6.2 Innovative Biopharmaceuticals 104

6.3 Biogenerics and Biosimilars 105

7 Segmentation of Europe Market by Therapeutic Area 106

7.1 Market Overview by Therapeutic Area 106

7.2 Oncology 108

7.3 Inflammatory and Infectious Diseases 109

7.4 Autoimmune Disorders 110

7.5 Metabolic Disorders 111

7.6 Hormonal Disorders 112

7.7 Cardiovascular Diseases 113

7.8 Neurological Diseases 114

7.9 Other Therapeutic Areas 115

8 European Market 2023-2033 by Country 116

8.1 Overview of European Market 116

8.2 Germany 119

8.3 U.K. 121

8.4 France 123

8.5 Spain 125

8.6 Italy 127

8.7 Netherlands 129

8.8 Rest of European Market 131

9 Competitive Landscape 133

9.1 Overview of Key Vendors 133

9.2 New Product Launch, Partnership, Investment, and M&A 137

9.3 Company Profiles 138

Abbott Laboratories 138

Amgen Inc. 140

Astrazeneca PLC 141

Bayer AG 142

Biogen Inc. 143

Bristol-myers Squibb Company (BMS) 144

Eli Lilly and Company 145

F. Hoffmann-La Roche Ltd. 146

Glaxosmithkline PLC 147

Johnson & Johnson 148

Merck & Co. Inc. 149

Novartis Ag 150

Novo Nordisk As 151

Pfizer Inc. 152

Sanofi Sa 153

Sharp Packaging Services 154

Sun Pharmaceutical Industries Ltd. 155

Takeda Pharmaceutical Company Limited 156

Thermo Fisher Scientific Inc. 157

Vertex Pharmaceuticals 158

WuXi AppTec 159

RELATED REPORTS 160

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Europe Biopharmaceuticals Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Is the Europe Biopharmaceuticals Market shifting its focus from growth to value?
Recognize the areas along the Europe Biopharmaceuticals Market's value chain where players are generating value. To get a complete picture, kindly read the entire report.
What years are taken into account in the Europe Biopharmaceuticals Market study?
The Europe Biopharmaceuticals Market study evaluates the year spans as follows: Historical year: 2019 to 2024; Base year: 2024; Forecast period**: 2025 to 2030 [** unless otherwise stated]
What are the advantages of the Europe Biopharmaceuticals Market research study?
The Europe Biopharmaceuticals Market research study aids businesses in strategic planning so that they may realize and gain business value from their growth strategies.
What is the CAGR at which the Europe Biopharmaceuticals Market can expand?
During the forecast years, the Europe Biopharmaceuticals Market can thrive with a robust CAGR.